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Rationale: We recently reported on the efficacy of a personalized transcranial
direct current stimulation (tDCS) treatment in reducing multiple sclerosis (MS) fatigue.
The result supports the notion that interventions targeted at modifying abnormal
excitability within the sensorimotor network could represent valid non-pharmacological
treatments.
Objective: The present work aimed at assessing whether the mentioned intervention
also induces changes in the excitability of sensorimotor cortical areas.
Method: Two separate groups of fatigued MS patients were given a 5-day tDCS
treatments targeting, respectively, the whole body somatosensory areas (S1wb) and the
hand sensorimotor areas (SM1hand). The study had a double blind, sham-controlled,
randomized, cross-over (Real vs. Sham) design. Before and after each treatment, we
measured fatigue levels (by the modified fatigue impact scale, mFIS), motor evoked
potentials (MEPs) in response to transcranial magnetic stimulation and somatosensory
evoked potentials (SEPs) in response to median nerve stimulation. We took MEPs and
SEPs as measures of the excitability of the primary motor area (M1) and the primary
somatosensory area (S1), respectively.
Results: The Real S1wb treatment produced a 27% reduction of the mFIS baseline level,
while the SM1hand treatment showed no difference between Real and Sham stimulations.
M1 excitability increased on average 6% of the baseline in the S1wb group and 40% in the
SM1hand group. Observed SEP changes were not significant and we found no association
between M1 excitability changes and mFIS decrease.
Conclusion: The tDCS treatment was more effective against MS fatigue when the
electrode was focused on the bilateral whole body somatosensory area. Changes in S1
and M1 excitability did not correlate with symptoms amelioration.
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Significance: The neuromodulation treatment that proved effective against MS fatigue
induced only minor variations of the motor cortex excitability, not enough to explain the
beneficial effects of the intervention.
Keywords: fatigue in multiple sclerosis, electroencephalography, transcranial magnetic stimulation, transcranial
direct current stimulation, magnetic resonance imaging, electrode personalization
Introduction
Fatigue is defined as “a feeling of insufficient physical and/or
mental energies interfering with the usual and desired activities”
(1). It is a common and highly disabling symptom in patients
affected by multiple sclerosis (MS) even when other symptoms
remain mild (2).
Involvement of the Motor Control System in
MS Fatigue
To date, there is no clear evidence pointing at a single factor
causing MS fatigue and fatigue complaints appear completely
unrelated to both clinical variables, such as type of MS, level of
disability, or disease duration, and demographic ones, such as age,
gender, and education level (3). Although peripheral conditions,
such as muscle weakness, may play a role, there are clear indi-
cations that much of MS fatigue has a central origin, most likely
being the consequence of a failing central motor transmission to
spinal alpha motor neurons (4).
tDCS Treatment Targeting “Whole Body S1” vs.
“Hand SM1”
A few years ago, Cogiamanian obtained an increase of endurance
against fatigue in healthy subjects by submitting them to a
transcranial direct current stimulation (tDCS) (5). Recently, we
applied Cogiamanian’s treatment to fatigued MS patients (6)
obtaining a significant amelioration of their symptoms. In the
present study, we tested two variations of Cogiamanian’s protocol
on two distinct subgroups of fatigued MS patients. We submitted
the first subgroup toCogiamanian’s same treatment only replacing
the original mono-hemispheric with a bihemispheric stimulation
(we will call this treatment SM1hand).
It is known that fatigued MS patients show a much higher
excitability of their primary motor area (M1) than non-fatigued
patients and healthy subjects. This phenomenon has been
attributed to a failure of intracortical inhibition (ICI) in frontal
and M1 areas, both before and after fatiguing exercises (4). Fur-
thermore, structural and functional data report a parietal involve-
ment inMS fatigue symptoms (7–9), with indications of a reduced
primary somatosensory area (S1) excitability (10, 11), and tDCS
has been reported to enhance parieto-frontal projections (12).
Also, in previous works of ours, we noticed signs of impaired
communication between S1 and M1 (13).
Consequently, on the base of the above considerations, for the
second subgroup, we modified Cogiamanian’s treatment to selec-
tively direct our neuromodulation on bihemispheric whole body
S1, avoiding further direct enhancement of M1 excitability (14).
Cogiamanian and coworkers assessed fatigue in hand movements
and stimulated the hand section of SM1 representation (5). We
considered that in MS patients, the lower limbs are also primarily
involved and there are no reasons to limit neuromodulation to
only the section of S1 devoted to hand representation. Thus, we
treated the second subgroup with a tDCS on bilateral whole body
S1 (we will call this treatment S1wb).
Aim
Within this theoretical frame, our present aim was to test whether
a tDCS treatment, which decreasesMS fatigue, induces changes in
brain excitability. In particular, we intended to quantify the effects
induced within M1 via transcranial magnetic stimulation (TMS)-
evokedmotor evoked potentials (MEPs) (15) and in S1 viamedian
nerve (MN) evoked somatosensory evoked potentials (SEPs).
Materials and Methods
The protocol was approved by the Ethics Committee of the
“S. Giovanni Calibita” Fatebenefratelli Hospital in Rome and
by Ethics Committee of Università degli Studi di Milano, Fon-
dazione IRCCS Ospedale Maggiore Policlinico, Mangiagalli e
Regina Elena.
Study Design
Both our studies (S1wb and SM1hand treatments) followed a
double blind, sham-controlled, randomized, cross-over design
(Sham/Real, Real/Sham). Patient remained blind to whether they
would receive a real or a sham treatment. Patients were asked to fill
out the modified fatigue impact scale (mFIS) form to score their
level of fatigue. We will refer to the week before the first tDCS
treatment as T0 (baseline) and to at least 4 h after the last tDCS
treatment as T1.We collected electroencephalographic (EEG) and
TMS sessions and mFIS scores at T0 and T1.
Sample Size Estimate
We calculated the sample size using the repeatability of mFIS
scores before neuromodulation treatments started. In 10 individu-
als withmildMS, we collectedmFIS twice, 1 week apart. The aver-
age mFIS pre–post score difference was 0.1 1.9, and the Intra-
Class Correlation indicated a very high agreement (ICC= 0.96;
p< 0.001). According to our previous study (6), the variability of
changes after stimulation was quite larger (21.1% after real, 16.9%
after sham). In order to assume the “worst” yet more realistic
scenario, we did not lean on homoscedasticity and assumed both
such variability values, distinguishing real and sham variances of
pre–post-stimulation changes. In Tecchio et al. (6), we observed
a 27% improvement after real and 7% improvement after sham
treatment. To recognize as significant (alpha level= 0.05), a 20%
difference between Real and Sham treatments, a sample size of 10
cases will provide a power of 90%. Notably, biomedical literature
considers a 25% improvement (ere expected for Real stimulation)
as a suitable threshold of clinical relevance (16) and here would
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correspond to a decrease of 12 mFIS points for a severely fatigued
patient with 48 at baseline.
Participants
We recruited 21 relapsing-remitting (RR) MS patients (17) expe-
riencing fatigue [physical items mFIS score>15, Ref. (18)]. Inclu-
sion criteria were as follows: mild physical disability [expanded
disability status scale, EDDS (19) cut-off score of 3], absence
of depression (no pharmacological treatment), absence of clinical
relapse, or radiological evidence of disease activity over the last
3months. Exclusion criteria were as follows: use of symptomatic
drugs, which may affect the level of fatigue, depression, and
anxiety within the past 3months (20), epilepsy or other cen-
tral/peripheral nervous system comorbidities and any systemic
conditions, whichmay cause fatigue (e.g., anemia and pregnancy).
All patients underwent brain magnetic resonance imaging (MRI)
for exclusion criteria assessment. In addition, a detailed clinical
history was collected including active disease modifying therapy
(DMT), disease duration, annual relapse rate, and depression level
(Beck depression inventory, BDI). Fine hand motor control was
evaluated by nine hole peg test (9HPT) scores collected separately
for left and right sides.
MRI Exam and Measure Estimate
Image Acquisition
In each patient undergoing S1wb treatment, brain imaging was
performed by an Achieva 1.5-T scanner (Philips Medical Sys-
tems, Best, The Netherlands), with 33mT/m gradients, online
2D/3D geometric distortion correction, and an 8-channels head
Phased-Array coil with parallel imaging capabilities (SENSE). All
sequences were acquired with contiguous slices and full brain
coverage.
Exclusion criteria (no active lesions) were assessed based on
T1-Spin Echo images before and 5min after intravenous injection
of a contrast agent. Lesions estimates were based on T2 Dual
Echo images (see: column 2 of Attachment 2) and 3D-FLAIR (see:
column 4 of Attachment 2).
T1-3D Fast Field Echo sequences with full brain coverage
(MPRAGE, TR/TE/FA= 8.6ms/4ms/8°; 170 contiguous sagittal
slices 1.2mm thick without gap, mtx1922) were used for the 3D
reconstruction of the brain structure in order to personalize the
tDCS electrode.
Image Post-Processing Computations
Lesion load
A semi-automated region of interest (ROI) approach was used
to trace hyperintense lesions in the white matter (WM) on T2-
weighted images, following strategies previously described [Ref.
(11); Jim 5.0, Xinapse Systems Ltd., Leicester, UK, Attachment 3].
ROIs were identified by consensus of two investigators (Giancarlo
Zito and D. Lupoi) blind to patients’ clinical data. The total lesion
volume (TLV) was computed. Lesion relative fraction (LrF) was
computed as the ratio of the TLV over the WM volume in order
to normalize for inter-subject head volume variability.
Whole Body S1 Personalized Electrode
Shaping and Positioning
Personalized Electrode Shaping
A few days before the experimental session, each subject under-
went a structural brain MRI exam with a 1.5-T scanner (Achieva,
Philips Medical Systems, Best, Netherlands; MPRAGE contigu-
ous sagittal slices with full brain coverage). MRI data were elab-
orated with SofTaxic Neuronavigation System ver. 2.0 (www.
softaxic.com, E.M.S., Bologna, Italy), which delivered the volu-
metric reconstruction of the individual brains and the cortical
folders. The stereotaxic procedure for the personalization of each
electrode included the following steps [Figure 1; (14)]: (1) the
line of the central sulcus shown by the navigator is manually
transferred onto a paper sheet firmly fixed onto the patient’s
scalp; (2) on paper, 2 cm-long segments are drawn perpendicu-
larly from a number of equidistant points of the central sulcus
line in the anterior direction. The number of equidistant points
is chosen to obtain a total electrode surface of 35 cm2, which the
literature widely reports as the recommended size for a direct
current intensity of 1.5mA. (3) The shape obtained on paper
is transferred onto a commercial band of conductive silicone.
The latter is 0.2mm thick and has a 1mm diameter channel
running along its length. The electrode is manually cut along the
contour, making sure that the channel remains roughly at the
center of the band’s length. (4) A standard electric wire, which
will deliver the 1.5mA direct current, is finally placed inside the
channel.
Following the SofTaxic navigator, the electrode was positioned
1.5 cmposterior and 0.5 cm anterior to the central sulcus, centered
on the nasion-inion line. Cathode electrode (6 cm 14 cm) was
FIGURE 1 |Whole body S1 personalized electrode. In one
exemplificative subject, we schematize the main steps of electrode
personalization [Ref. (14), see Materials and Methods). (A) After drawing
the left and right central sulci using SoftTaxic software from individual 3D
MRI, we fit this line by 2 cm wide parallelograms and we cut the electrode
from a conductive silicon band. (B) We position the personalized
stimulating electrode by proper neuronavigation procedure along the
central sulcus with the center of the electrode crossing the nasion-inion
line. (C) S1wb personalized electrode and the cathode electrode
positioned on Oz.
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positioned on Oz. Contact with the subject’s head was facilitated
by a conductive gel and an elastic cotton net maintained the
electrodes stable along the entire session (Figure 1).
Transcranial Direct Current Stimulation
(5-Day Treatment)
Transcranial direct current stimulation was delivered by an elec-
trical stimulator through a constant current unit and an isolation
unit [SM1 (21); S1-Eldith Stimulator by NeuroConn, Ilmenau,
Germany]. Anode electrode was positioned as described above.
Cathode electrodewas under the chin for the SM1 stimulation and
on Oz for the S1 stimulation.
The 1.5-mA constant current was applied for 15min once a day
for five consecutive days, according to previous studies against
pain (22, 23). In particular, a 1.5-mA current strength produces
a current density of about 0.04mA/cm2 for the anode electrode
of 35 cm2 (5, 24), which is well below safety thresholds. Cathode
electrode size was of 84 cm2, resulting in a current density of
0.02mA/cm2 under this electrode, corresponding to a non-effect
current density in this reference region (25, 26). Impedances
were below 10 kΩ throughout the stimulations. Sham condition
consisted of 4 s of active stimulation at the beginning and at the
end of each day’s 15-min stimulation. At debriefing, no subject
reported to feel any difference across tCSs.
Transcranial Magnetic Stimulation to Probe
Cortical Excitability Changes in M1
Single-pulse TMS was performed through a standard focal coil
(diameter of eachwing 70mm) connected with a Bistim 200mod-
ule (The Magstim Company Ltd., Whitland, UK). We recorded
TMS MEPs from left and right opponens pollicis (OP) by surface
electrodes in a belly tendon montage (2.5 cm apart). Following
international standards, we identified the “hot-spot” of the right
OPmuscle and the corresponding restingmotor threshold (RMT)
(27, 28). Thereafter, we maintained the coil position – digitized
and monitored throughout the whole session by the SofTaxic
neuronavigator – by means of a support arm (Figure 2A).
Transcranialmagnetic stimulation intensity was settled at 120%
RMT and 20 MEPs were then collected in complete relaxation
while TMS was delivered with an inter-stimulus interval ran-
domly ranging between 5 and 7 s. The whole procedure was
repeated in the other hemisphere to obtain left OP motor cortical
representation.
Electroencephalographic Study to Probe Cortical
Excitability Changes in S1
Electrophysiological Data Recording
Electroencephalographic signals were recorded with a 64-channel
actiChamp System (Brain Products GmbH, Gilching, Germany,
Figure 2B). The montage included Fz derivation for reference
and FPz for ground. EEG signals were sampled at 5 kHz and a
preconditioning 0.1–1500Hz bandpass filtering was applied.
Median Nerve Stimulation
All subjects sat comfortably on an armchair during the experi-
ment. In order to induce somatosensory evoked responses fol-
lowing a painless thumb twitch, their MN was stimulated at the
wrist with a constant current electrical stimulator (Model DS3,
Digitimer Ltd., Hertfordshire, UK), using standard parameters
(cathode proximal, 250ms inter-stimulus interval, 0.2ms dura-
tion, above motor threshold intensity).
Left and right MNs were separately stimulated for 5.5min,
totaling about 1300 artifact-free trials, which were stored for
off-line analysis. The SEP epochs ranged from 10ms pre to
100ms post-stimulus. Epochs whose voltage amplitudes exceeded
100µV at the EOG electrode as well as those containing saturat-
ing artifacts were rejected.
All amplitude values referred to the 5–10ms post-stimulus
interval. The amplitude of the N20 component was measured
as the first negative peak between 18 and 23ms. The N20–P25
complex was determined as the difference between the N20 peak
and the subsequent positivity peak (P25), occurring at a latency of
around 23–29ms.
For purposes of the present study, we used the typical bipolar
derivation used to assess SEPs [C3–C4, Ref. (29)].
FIGURE 2 | Transcranial magnetic stimulation and EEG settings for brain plasticity assessment. Experimental settings for the MEP (A) and SEP
(B) recordings.
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Statistical Analysis
After checking the distribution of MEP and SEP amplitudes (as
tested by Shapiro–Wilk test), we applied, when necessary, suitable
transformations in order to achieve a better approximation to
gaussianity and a good control of outliers.
To test the effects of the 5-day tDCS on MFIS, MEP, and SEP
variables, analyses of variance (ANOVA) for repeated measures
were performed with Stimulation (Real, Sham) and Treatment
(pre-, post-tDCS treatment) as within-subjects factors. Within-
subjects factorHemisphere (Left, Right) was included forMEP and
SEP, which had been collected bilaterally since we performed a
bilateral stimulation. A similar approach was used for the effects
on fine hand motor control measure, with the 9HPT submitted to
the ANOVAwith tDCS Intervention (Pre, Post), Stimulation (Real,
Sham), and Hand (Right, Left) within-subjects factors. We per-
formed separate ANOVA designs in the two patients’ subgroups
stimulated on bilateral S1wb or SM1hand. Significance threshold
was set to 0.050 and we reported trends for p< 0.100.
Results
The 21 patient cohorts presented a mild clinical picture in accor-
dance to the inclusion criteria (Table 1). The two electrode-
dependent subgroups displayed homogenous clinical features
(Table 1).
Fatigue Levels
Whole Body S1 Stimulation (S1wb)
Analyses of variance indicated that mFIS changes were related to
the type of stimulation (Real or Sham) when the bilateral per-
sonalized S1wb electrode was used [StimulationTreatment inter-
action F(1,8)= 9.692, p= 0.014, (6), Table 2]. Fatigue resulted
reduced after real stimulation (post hoc comparison p= 0.002,
31.0 12.0 post- vs. 42.1 7.9 pre-stimulation), whereas there
were no changes after the sham stimulation [post hoc comparison
p= 0.901, 34.8 10.4 post- vs. 37.2 7.0 pre-stimulation, (6),
Table 2]. After real stimulation, the mean fatigue reduction was
28% of the baseline (range between 2 and 76%), and 8% after sham
(range between 11 and 38%, paired-samples t-test real vs. sham,
p= 0.016).
TABLE 1 | Demographic and clinical profile of people with MS.
Sex Age Dis Dur EDSS BDI mFIS LrF 9HPT
S1wb 9F/4M 45.8 7.6 1.5 12.7 41.6a 0.38 20.8
(7.6) (8.2) [0–3.5] (3.5) (7.5)a (0.48) (4.9)
SM1handb 6F/2M 38.1 13.5 2 11.0 57.1
(9.8) (4.2) [1–2.5] (5.1) (19.9)
p 0.080 0.068 0.254 0.438 0.062
M, male; F, female; Mean or Median in italics and SD, standard deviations () or ranges
[min, max] across the group of: Dis Dur, disease duration; Scores of: EDSS, expanded
disability status scale; BDI, Beck depression inventory; LrF, lesion relative factor; MFIS,
modified fatigue impact scale, and 9HPT, time (s) to execute right hand 9-Hole Peg Test
at baseline.
amFIS 1-week apart repetition was 41.5, SD 6.1 (see Study Design). MRI-derived
measures (LrF) and 9HPT were not collected in the SM1hand group.
bTwo out of the 10 patients of the SM1hand group dropped out. In the last row, the
significance og the comparison between the two groups.
TABLE 2 | Transcranial direct current stimulation treatment effects on
fatigue.
Real Sham
T0 T1 T0 T1 p
S1wb 42.1 31.0 37.2 34.7 0.014
(7.9) (12.0) (7.0) (10.4)
SM1hand 57.8 42.1 55.5 52.1 0.239
(19.9) (17.2) (26.6) (22.0)
Mean and SD of fatigue scale (mFIS) across patients before and after 5-day tDCS
treatment, stimulating bilateral either whole body S1 (S1wb) or hand section of SM1
(SM1hand). p is the significance of the Stimulation Treatment interaction effect. In
bold, values with significant difference between pre- and post-treatment, as estimated
by post-hoc comparison whenever the Stimulation Treatment interaction effect was
significant.
tDCS Treatment Effect on Fine Hand Motor
Control (9HPT)
In the S1wb group, 9HPT of the right hand correlated with both
EDSS and physical items of MFIS (Pearson’s r= 0.736, p= 0.015
and r= 0.744, p= 0.014, respectively). It should be noted that the
correlation between MFIS_phys and 9HPT remains substantially
stable after correction for EDSS (partial correlation r= 0.602,
p= 0.086). The lesion load was not associated with any clinical
or fatigue-related measure (LrF with EDSS, BDI, total or physical
MFIS p> 0.200 consistently).
The full model ANOVA evidenced, in addition to the right
hand performing better than the left [Hand factor F(1,8)= 5.749,
p= 0.043, overall average 20.3 4.6 and 22.6 4.3 s, respectively],
that the two hands’ performances were differently affected by
the intervention [Hand (Right, Left) tDCS intervention (Pre,
Post) Stimulation(Real, Sham) effect F(1,8)= 5.697, p= 0.044].
Repeating the reduced models for each hand separately, we
observed that the left hand did not change after the 5-day stimula-
tion, while the right hand 9HPT changed in terms of dependence
on whether the stimulation was real or sham [Stimulation tDCS
intervention effect F(1,8)= 5.680, p= 0.044]. The post hoc com-
parison showed that, after the real stimulation, the time required
to execute the 9HPT decreased (two-tails paired t-test p= 0.038,
with average 21.1 4.9 pre and 19.8 3.8 s post values], while it
was unchanged by sham stimulation (t-test p= 0.401). No associ-
ation emerged among post-tDCS values of MFIS regarding either
total or physical and 9HPT scores.
Hand SM1 Stimulation (SM1hand)
No interaction StimulationTreatment effect was observed when
SM1hand electrode was used (p> 0.200, Table 2), indicating that
effects of real and sham stimulations on fatigue levels were not
clearly different.
M1 Excitability
No differences were observed in RMTs, stimulation intensities
or MEP latencies when compared between hemispheres, between
stimulation types (Real or Sham) or treatments (pre–post-
stimulation) (p> 0.200 consistently). In the S1wb group, the mean
of RMT across all conditions was 58.4 2.6% of the maximal
stimulator output, TMS intensity was 70.2 3.1%, MEP latency
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was 27.3 3.2ms. In the SM1hand group, the RMT decreased after
stimulation (paired-samples t-test p= 0.004; pre 59.2 18.8 and
post 55.0 17.9% of the maximal stimulator output), while the
latency did not change 24.4 2.6ms. MEP latency was associ-
ated to the MS severity (EDSS–MEP latency Pearson’s coefficient
r= 0.880, p= 0.021).
Motor evoked potential amplitude distribution definitely dif-
fered from a Gaussian and we obtained a good fit by natural loga-
rithmic transformation (Shapiro–Wilk p> 0.200 consistently).
No association was evident between the order of MEP
collection and its amplitude (Pearson’s correlation p= 0.607).
Mean MEP amplitude, estimated as exponential back-
transformation of mean of logarithm-transformed MEP
amplitudes, were 171.5 1.8 for the right OP and 145.3 1.9
for the left OP. No difference of baseline MEP amplitudes was
observed between Real and Sham stimulations (t-test p= 0.380
averaging right and left values).
In the S1wb group, the ANOVA on the MEP amplitude showed
a trend interaction effect StimulationTreatment (p= 0.073),
which corresponded to an increase of MEP amplitude after the
real stimulation (Treatment effect, p= 0.037), absent after Sham
(p= 0.275). The average increase with respect to the baseline level
was 6.0% ranging between 0.2 and 22.6% of baseline level (MEP-
post–MEPpre/MEPpre of logarithm-transformed MEP ampli-
tudes averages).
In the SM1hand group, MEP amplitude increased after the real
stimulation (Treatment effect, p= 0.021). The average increase
with respect to the baseline level was 40.4% ranging between 16.7
and 76.0% of baseline level.
No association emerged among post-tDCS MEP values and
9HPT scores.
S1 Excitability
No effects were observed in the N20 SEP component between the
two hemispheres or the two stimulations (pre–post-stimulation,
Real or Sham, p> 0.200 consistently). The N20–P25 complex
showed a tendency to increasing after the stimulation, but no
StimulationTreatment effect was found (p> 0.200).
Relationships Between S1 and M1 Excitability
and MFIS Variations
Fatigue level changes did not correlate with variations in M1
excitability in either of the S1wb or SM1hand subgroups (p> 0.200
in both cases).
Discussion
Our 5-day tDCS stimulation targeting the bihemispheric whole
body somatosensory region significantly decreased MS fatigue.
In addition, hand muscle MEPs showed that that stimulation
modified M1 excitability, whereas MN SEPs showed no evidence
of changes in S1 excitability.
Mechanisms Behind Regional Dependence of
tDCS Treatment Efficacy (i.e., S1-Whole Body vs.
SM1-Hand)
Overall, the 5-day tDCS treatment targeting the bilateral S1wb
representation showed the StimulationTreatment effect, which
TABLE 3 | Intra-cohort fatigue levels correlation.
S1wb SM1hand
ρ p ρ p
Real vs. Sham T0 0.718 0.045  0.299 0.471
Real T0 vs. T1 0.840 0.002 0.403 0.323
Sham T0 vs. T1 0.957 0.000  0.054 0.900
Pearson’s correlation coefficients (ρ) and significance (p) between real and sham baseline
mFIS scores (T0) and between mFIS scores at baseline (T0) and after-treatment (T1) both
after real (second row) and sham (third row) treatments, for both the SM1hand and S1wb
subgroups. In bold, significant correlations.
was lacking in the SM1hand intervention. Noteworthy, the aver-
age decrease in mFIS score was 15.6 after real SM1hand stimula-
tion – larger than the 11.1 point decrease observed after real S1wb
stimulation, with similar baseline levels – and the specific paired t-
test comparison was significant (p= 0.030).We also analyzed why
an average net (real minus sham) SM1 effect of 15.6–3.4= 12.2
was not significant while an average net S1 effect of 11.1–2.4= 8.7
was significant, with comparable SD (a little bit larger in S1,
indeed) (although such a comparison is irrelevant in the absence
of a significant interaction). The reason lies in the different cor-
relation patterns: within the SM1hand subgroup, correlations are
absent between Sham and Real baseline levels, as well as between
fatigue scale values from other time points, contrasting clear (and
expected) correlations in the S1wb subgroup (Table 3).
The S1wb treatment was more effective than over SM1hand
(21) and than over the left prefrontal cortex (30). This compar-
ative result strengthens the working hypothesis, which guided the
development of the S1-whole body personalized electrode. In fact,
data available in the literature document a failure of the inhibitory
mechanisms in the frontal and primarymotor (M1) areas involved
inmotor planning (4), a reducedM1 ICI before and after fatiguing
exercises (4), and an increase in M1 excitability (4) in fatigued
vs. non-fatigued MS patients and to healthy subjects. Concur-
rently, together with excessive excitability of M1, we observed
signs of a reduced S1 excitability (10). Moreover, we observed an
altered parieto-frontal projection, mainly involving S1 andM1, in
fatigued vs. non-fatigued MS patients (13, 31). Thus, we decided
to neuromodulate to enhance selectively the excitability of S1,
avoiding a direct enhancement of M1 excitability (as occurs with
SM1 electrode), to further support the parieto-frontal projection
already observed by tDCS (12).
Suitability of Differentiated Effects Targeting S1
vs. SM1
Transcranial direct current stimulation-generated modulations of
cortical excitability can be focused by means of proper sizing and
positioning of the stimulation electrode. Since tDCS efficacy is
determined by the current density (i.e., current strength/electrode
area), we can obtain increased focality by reducing the electrode
size while keeping a constant current strength. In the motor sys-
tem, Nitsche and colleagues (32) compared tDCS effects on cen-
tral representations of two muscles, first dorsal interosseus (FDI)
and abductor digiti minimi (ADM), by measuring MEPs. Stim-
ulation with small electrodes (3.5 cm2) generated focal effects,
with different MEP amplitude increases for the two muscles (32).
The protocol we are proposing actually requires less focality than
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Nitsche’s, where a discrimination of M1 neuronal pools control-
ling the two hand muscles was sought. In fact, we intend to
stimulate motor vs. sensory regions. However, while positioning
of tDCS electrodes in M1 stimulation can be guided by TMS,
which induces responses from specificmuscles, a neuronavigation
system is requiredwhen stimulating S1 vs.M1 to precisely identify
the central sulcus. Modern frameless stereotaxic systems allow
navigation on the subject’s structuralMRI-derived brain represen-
tation, providing high-spatial precision with accuracy in the range
of millimeters (33). In our experimental setup, we used precise
topographical determination of the central sulcus in placing the
S1wb electrode (6, 14, 25, 34).
tDCS Targeting Bilateral vs. Mono-Hemispheric
Regions
Multiple sclerosis fatigue is not associated to mono-hemispheric
prevalence, as shown by electrophysiological (10) and neuroimag-
ing data (9). Thus, via the tDCS intervention, we targeted bilateral
(35) either whole body S1 or hand SM1. In the present results,
we observed bilateral M1 enhancement, documenting that bilat-
eral stimulations of a homologous area do not cancel out. This
hypothesis of ineffective bilateral M1 stimulation is derived from
the well-knownmotor system organization, withM1 of one hemi-
sphere inhibiting M1 of the other hemisphere. Through bilateral
stimulation of homologous M1 areas, the concurrent increase of
inhibition induced by the increase in excitability of one hemi-
sphere might thus cancel out the increase in excitability in the
other hemisphere. However, we can reject such a hypothesis, and
we can also speculate that a relevant component of the presently
observed neuromodulation operates directly on local pyramidal
neurons, and not via inhibitory or excitatory networks beneath
the electrode (36, 37).
Brain Plasticity Induced by S1 Stimulation
We did not find evidence of S1 excitability changes induced by
S1wb tDCS treatment, as measured by the typical SEP assessment.
This can be due to two causes. The first is that the SEP gives an
indirect assessment of cortical pyramidal neurons with respect to
TMS-derived MEP. In fact, TMS stimulates pyramidal neurons
and theMEPmuscle response gives ameasure of cortical excitabil-
ity with as a single-station-pathway (only the spinal cord relay
in between). Instead, the pathway between MN stimulation and
S1 (here assessed by single-derivation SEP) includes spinal cord,
brain stem, and thalamic relays. The second reason can be poor
sensitivity of EEG-derived SEP analysis. In addition, we found
more effects inM1 than in S1,which can be due to non-selective S1
stimulation. Via simulations (in progress), we are in fact observing
that the induced current density is slightly prevalent in S1 but it is
of a comparable intensity also in M1.
Study Limitations
We did not study the two datasets (S1wb and SM1hand 5-day tDCS
treatments) in a single statistical model, since a different anode
electrode size (anode electrode area of 70 cm2 for SM1 and 352
for S1) and a different reference position (on Oz or on the left
shoulder) were used.
Here, we investigated somatosensory evoked responses, since
we performed a stimulation planned to focus on S1. We started
from a standard single derivation in each hemisphere to assess
SEP changes. Nevertheless, we collected 64-channel EEG data
to further investigate cortical effects. In particular, source anal-
ysis will allow future investigations of our main hypothesis of a
modification induced by the tDCS treatment on sensory-motor
functional connectivity.
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